Receptor FAS (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor FAS" in Spanish language version.

refsWebsite

Global rank Spanish rank

15nih.gov

4^th place

15doi.org

2^nd place

3harvard.edu

18^th place

34^th place

3semanticscholar.org

11^th place

79^th place

2web.archive.org

1^st place

1univ-montp2.fr

low place

1broadinstitute.org

low place

1wiley.com

222^nd place

135^th place

broadinstitute.org

«Tumorscape». The Broad Institute. Archivado desde el original el 14 de abril de 2012. Consultado el 5 de julio de 2012.

doi.org

dx.doi.org

Lichter P.,; Walczak H.; Weitz S.; Behrmann I.; Krammer PH. (1992). «The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19». Genomics 14 (1): 179-180. PMID 1385299. doi:10.1016/S0888-7543(05)80302-7.
Nagata S. (July 2004). «Early work on the function of CD95, an interview with Shige Nagata». Cell Death and Differentiation. 11 Suppl 1 (Suppl 1): S23-7. PMID 15143352. doi:10.1038/sj.cdd.4401453.
Wajant H. (May 2002). «The Fas signaling pathway: more than a paradigm». Science 296 (5573): 1635-6. PMID 12040174. doi:10.1126/science.1071553.
Izquierdo JM.; Majós N.; Bonnal S.; Martínez C.; Castelo R.; Guigó R.; Bilbao D.; Valcárcel J. (August 2005). «Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition». Molecular Cell 19 (4): 475-484. PMID 16109372. doi:10.1016/j.molcel.2005.06.015.
Wang L.; Yang JK.; Kabaleeswaran V.; Rice AJ.; Cruz AC.; Park AY.; Yin Q.; Damko E.; Jang SB.; Raunser S.; Robinson CV.; Siegel RM.; Walz T.; Wu H. (November 2010). «The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations». Nature Structural & Molecular Biology 17 (11): 1324-9. PMC 2988912. PMID 20935634. doi:10.1038/nsmb.1920.
Huang B.; Eberstadt M.; Olejniczak ET.; Meadows RP.; Fesik SW. (1996). «NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain». Nature 384 (6610): 638-41. Bibcode:1996Natur.384..638H. PMID 8967952. S2CID 2492303. doi:10.1038/384638a0.
Eberstadt M.; Huang B.; Chen Z.; Meadows RP.; Ng SC.; Zheng L.; Lenardo MJ.; Fesik SW. (April 1998). «NMR structure and mutagenesis of the FADD (Mort1) death-effector domain». Nature 392 (6679): 941-5. Bibcode:1998Natur.392..941E. PMID 9582077. S2CID 4370202. doi:10.1038/31972.
Chen L.; Park SM.; Tumanov AV.; Hau A.; Sawada K.; Feig C.; Turner JR.; Fu YX.; Romero IL.; Lengyel E.; Peter ME. (May 2010). «CD95 promotes tumour growth». Nature 465 (7297): 492-6. Bibcode:2010Natur.465..492C. PMC 2879093. PMID 20505730. doi:10.1038/nature09075.
Liu F.; Bardhan K.; Yang D.; Thangaraju M.; Ganapathy V.; Waller JL.; Liles GB.; Lee JR. et al. (July 2012). «NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression». The Journal of Biological Chemistry 287 (30): 25530-40. PMC 3408167. PMID 22669972. doi:10.1074/jbc.M112.356279.
Yang D.; Torres CM.; Bardhan K.; Zimmerman M.; McGaha TL.; Liu K. (May 2012). «Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo». Journal of Immunology 188 (9): 4441-9. PMC 3398838. PMID 22461695. doi:10.4049/jimmunol.1103035.
Fleischer B. (August 1986). «Lysis of bystander target cells after triggering of human cytotoxic T lymphocytes». European Journal of Immunology 16 (8): 1021-4. PMID 3488908. S2CID 27562316. doi:10.1002/eji.1830160826.
Smyth MJ.; Krasovskis E.; Johnstone RW. (July 1998). «Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes». Journal of Virology 72 (7): 5948-54. PMC 110399. PMID 9621057. doi:10.1128/JVI.72.7.5948-5954.1998.
Upadhyay R.; Boiarsky JA.; Pantsulaia G.; Svensson-Arvelund J.; Lin MJ.; Wroblewska A.; Bhalla S.; Scholler N.; Bot A.; Rossi JM.; Sadek N.; Parekh S. (December 2020). «A critical role for fas-mediated off-target tumor killing in T cell immunotherapy». Cancer Discovery 11 (3): 599-613. PMID 33334730. doi:10.1158/2159-8290.CD-20-0756.
Ross SL.; Sherman M.; McElroy PL.; Lofgren JA.; Moody G.; Baeuerle PA.; Coxon A.; Arvedson T. (24 de agosto de 2017). «Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing». PLOS ONE 12 (8): e0183390. PMC 5570333. PMID 28837681. doi:10.1371/journal.pone.0183390.
Gajate C.; Mollinedo F. (March 2005). «Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy». The Journal of Biological Chemistry 280 (12): 11641-7. PMID 15659383. doi:10.1074/jbc.M411781200.

harvard.edu

adsabs.harvard.edu

Huang B.; Eberstadt M.; Olejniczak ET.; Meadows RP.; Fesik SW. (1996). «NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain». Nature 384 (6610): 638-41. Bibcode:1996Natur.384..638H. PMID 8967952. S2CID 2492303. doi:10.1038/384638a0.
Eberstadt M.; Huang B.; Chen Z.; Meadows RP.; Ng SC.; Zheng L.; Lenardo MJ.; Fesik SW. (April 1998). «NMR structure and mutagenesis of the FADD (Mort1) death-effector domain». Nature 392 (6679): 941-5. Bibcode:1998Natur.392..941E. PMID 9582077. S2CID 4370202. doi:10.1038/31972.
Chen L.; Park SM.; Tumanov AV.; Hau A.; Sawada K.; Feig C.; Turner JR.; Fu YX.; Romero IL.; Lengyel E.; Peter ME. (May 2010). «CD95 promotes tumour growth». Nature 465 (7297): 492-6. Bibcode:2010Natur.465..492C. PMC 2879093. PMID 20505730. doi:10.1038/nature09075.

nih.gov

ncbi.nlm.nih.gov

Lichter P.,; Walczak H.; Weitz S.; Behrmann I.; Krammer PH. (1992). «The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19». Genomics 14 (1): 179-180. PMID 1385299. doi:10.1016/S0888-7543(05)80302-7.
Nagata S. (July 2004). «Early work on the function of CD95, an interview with Shige Nagata». Cell Death and Differentiation. 11 Suppl 1 (Suppl 1): S23-7. PMID 15143352. doi:10.1038/sj.cdd.4401453.
Wajant H. (May 2002). «The Fas signaling pathway: more than a paradigm». Science 296 (5573): 1635-6. PMID 12040174. doi:10.1126/science.1071553.
Izquierdo JM.; Majós N.; Bonnal S.; Martínez C.; Castelo R.; Guigó R.; Bilbao D.; Valcárcel J. (August 2005). «Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition». Molecular Cell 19 (4): 475-484. PMID 16109372. doi:10.1016/j.molcel.2005.06.015.
Wang L.; Yang JK.; Kabaleeswaran V.; Rice AJ.; Cruz AC.; Park AY.; Yin Q.; Damko E.; Jang SB.; Raunser S.; Robinson CV.; Siegel RM.; Walz T.; Wu H. (November 2010). «The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations». Nature Structural & Molecular Biology 17 (11): 1324-9. PMC 2988912. PMID 20935634. doi:10.1038/nsmb.1920.
Huang B.; Eberstadt M.; Olejniczak ET.; Meadows RP.; Fesik SW. (1996). «NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain». Nature 384 (6610): 638-41. Bibcode:1996Natur.384..638H. PMID 8967952. S2CID 2492303. doi:10.1038/384638a0.
Eberstadt M.; Huang B.; Chen Z.; Meadows RP.; Ng SC.; Zheng L.; Lenardo MJ.; Fesik SW. (April 1998). «NMR structure and mutagenesis of the FADD (Mort1) death-effector domain». Nature 392 (6679): 941-5. Bibcode:1998Natur.392..941E. PMID 9582077. S2CID 4370202. doi:10.1038/31972.
Chen L.; Park SM.; Tumanov AV.; Hau A.; Sawada K.; Feig C.; Turner JR.; Fu YX.; Romero IL.; Lengyel E.; Peter ME. (May 2010). «CD95 promotes tumour growth». Nature 465 (7297): 492-6. Bibcode:2010Natur.465..492C. PMC 2879093. PMID 20505730. doi:10.1038/nature09075.
Liu F.; Bardhan K.; Yang D.; Thangaraju M.; Ganapathy V.; Waller JL.; Liles GB.; Lee JR. et al. (July 2012). «NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression». The Journal of Biological Chemistry 287 (30): 25530-40. PMC 3408167. PMID 22669972. doi:10.1074/jbc.M112.356279.
Yang D.; Torres CM.; Bardhan K.; Zimmerman M.; McGaha TL.; Liu K. (May 2012). «Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo». Journal of Immunology 188 (9): 4441-9. PMC 3398838. PMID 22461695. doi:10.4049/jimmunol.1103035.
Fleischer B. (August 1986). «Lysis of bystander target cells after triggering of human cytotoxic T lymphocytes». European Journal of Immunology 16 (8): 1021-4. PMID 3488908. S2CID 27562316. doi:10.1002/eji.1830160826.
Smyth MJ.; Krasovskis E.; Johnstone RW. (July 1998). «Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes». Journal of Virology 72 (7): 5948-54. PMC 110399. PMID 9621057. doi:10.1128/JVI.72.7.5948-5954.1998.
Upadhyay R.; Boiarsky JA.; Pantsulaia G.; Svensson-Arvelund J.; Lin MJ.; Wroblewska A.; Bhalla S.; Scholler N.; Bot A.; Rossi JM.; Sadek N.; Parekh S. (December 2020). «A critical role for fas-mediated off-target tumor killing in T cell immunotherapy». Cancer Discovery 11 (3): 599-613. PMID 33334730. doi:10.1158/2159-8290.CD-20-0756.
Ross SL.; Sherman M.; McElroy PL.; Lofgren JA.; Moody G.; Baeuerle PA.; Coxon A.; Arvedson T. (24 de agosto de 2017). «Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing». PLOS ONE 12 (8): e0183390. PMC 5570333. PMID 28837681. doi:10.1371/journal.pone.0183390.
Gajate C.; Mollinedo F. (March 2005). «Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy». The Journal of Biological Chemistry 280 (12): 11641-7. PMID 15659383. doi:10.1074/jbc.M411781200.

semanticscholar.org

api.semanticscholar.org

Huang B.; Eberstadt M.; Olejniczak ET.; Meadows RP.; Fesik SW. (1996). «NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain». Nature 384 (6610): 638-41. Bibcode:1996Natur.384..638H. PMID 8967952. S2CID 2492303. doi:10.1038/384638a0.
Eberstadt M.; Huang B.; Chen Z.; Meadows RP.; Ng SC.; Zheng L.; Lenardo MJ.; Fesik SW. (April 1998). «NMR structure and mutagenesis of the FADD (Mort1) death-effector domain». Nature 392 (6679): 941-5. Bibcode:1998Natur.392..941E. PMID 9582077. S2CID 4370202. doi:10.1038/31972.
Fleischer B. (August 1986). «Lysis of bystander target cells after triggering of human cytotoxic T lymphocytes». European Journal of Immunology 16 (8): 1021-4. PMID 3488908. S2CID 27562316. doi:10.1002/eji.1830160826.

univ-montp2.fr

orthomam.univ-montp2.fr

«OrthoMaM phylogenetic marker: FAS coding sequence». Archivado desde el original el 3 de marzo de 2016. Consultado el 2 de diciembre de 2009.

web.archive.org

«OrthoMaM phylogenetic marker: FAS coding sequence». Archivado desde el original el 3 de marzo de 2016. Consultado el 2 de diciembre de 2009.
«Tumorscape». The Broad Institute. Archivado desde el original el 14 de abril de 2012. Consultado el 5 de julio de 2012.

wiley.com

onlinelibrary.wiley.com

Fleischer B. (August 1986). «Lysis of bystander target cells after triggering of human cytotoxic T lymphocytes». European Journal of Immunology 16 (8): 1021-4. PMID 3488908. S2CID 27562316. doi:10.1002/eji.1830160826.